Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00550563 · ClinicalTrials.gov registry record · NA
DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00550563 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 50 participants.
The verdict
NCT00550563, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is studying changes in DNA that affect vitamin D metabolism in patients with colorectal cancer receiving vitamin D supplements.
Interventions
- GENETIC protein expression analysis
- GENETIC polymerase chain reaction
- GENETIC polymorphism analysis
- GENETIC reverse transcriptase-polymerase chain reaction
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00550563
The ClinicalTrials.gov registry entry for NCT00550563 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which protein expression analysis is the first listed.
NCT00550563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00550563 about?
NCT00550563 is a clinical study titled "DNA Changes That Affect Vitamin D Metabolism in Patients With Colorectal Cancer Receiving Vitamin D Supplements". RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This clinical trial is studying changes in DNA that affect vitamin D metabolism in patients with colorecta...
What is the current status of trial NCT00550563?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2007-08. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00550563?
The interventions under investigation include: protein expression analysis (GENETIC), polymerase chain reaction (GENETIC), polymorphism analysis (GENETIC), reverse transcriptase-polymerase chain reaction (GENETIC), cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00550563?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.